Fan Yu, Xiaoran Li, Yue Zhang, Yi Shan, Bixiao Cui, Liqun Jiao, Jie Lu
{"title":"MRI ensemble model of plaque and perivascular adipose tissue as PET-equivalent for identifying carotid atherosclerotic inflammation.","authors":"Fan Yu, Xiaoran Li, Yue Zhang, Yi Shan, Bixiao Cui, Liqun Jiao, Jie Lu","doi":"10.1186/s13550-025-01293-9","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Severe cerebrovascular events are associated with carotid atherosclerotic plaque progression and rupture that is mediated by inflammation. <sup>18</sup>F-fluorodeoxyglucose ([<sup>18</sup>F]FDG) PET is important for assessing the inflammation of carotid atherosclerotic plaque, but it suffers from the limitations of radiation exposure. Additionally, inflammation of perivascular adipose tissue (PVAT) has been found to promote atherosclerosis progression through paracrine signaling mechanisms. The study aimed to develop an ensemble model based on carotid plaque and PVAT MRI radiomics for identifying highly inflammatory plaques (HIPs).</p><p><strong>Results: </strong>159 asymptomatic carotid atherosclerosis patients (137 males; 65 ± 8 years old) with 209 plaques (104 HIPs) were consecutively enrolled. 47.95% (70/146) of cases and 53.97% (34/63) were defined as HIPs in the training and testing datasets, respectively. There was more lipid core, more intraplaque hemorrhage, and less calcification in the HIPs compared to the non-highly inflammatory plaques (NHIPs) in the training dataset (p = 0.002, 0.019, and 0.013, respectively). Notably, the incidence of indistinct PVAT (IPVAT) in HIPs was higher than that in NHIPs, both in the training (81.43% vs. 46.05%; p < 0.001) and the testing (88.24% vs. 58.62%; p = 0.007) datasets. The correlations between plaque MRI characteristics and [<sup>18</sup>F]FDG uptake differed between the NHIPs and HIPs. However, IPVAT consistently correlated with SUV<sub>max</sub> (r = 0.35, 0.30; p < 0.001, p = 0.002; for NHIPs and HIPs, respectively). The ensemble model that integrates the radiomics of carotid plaque and PVAT outperformed all models in predicting HIP (area under the curve [AUC] = 0.92/0.91, training/testing dataset). The follow-up further validated the PET for predicting plaque progression with the same accuracy as the ensemble model (AUC: 0.85 vs. 0.79).</p><p><strong>Conclusions: </strong>The ensemble model integrating the radiomics of carotid plaque and perivascular adipose tissue provides an equivalent tool to PET in the visualization of the evaluation of carotid atherosclerosis inflammation and progression.</p>","PeriodicalId":11611,"journal":{"name":"EJNMMI Research","volume":"15 1","pages":"103"},"PeriodicalIF":3.1000,"publicationDate":"2025-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12328859/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"EJNMMI Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13550-025-01293-9","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Severe cerebrovascular events are associated with carotid atherosclerotic plaque progression and rupture that is mediated by inflammation. 18F-fluorodeoxyglucose ([18F]FDG) PET is important for assessing the inflammation of carotid atherosclerotic plaque, but it suffers from the limitations of radiation exposure. Additionally, inflammation of perivascular adipose tissue (PVAT) has been found to promote atherosclerosis progression through paracrine signaling mechanisms. The study aimed to develop an ensemble model based on carotid plaque and PVAT MRI radiomics for identifying highly inflammatory plaques (HIPs).
Results: 159 asymptomatic carotid atherosclerosis patients (137 males; 65 ± 8 years old) with 209 plaques (104 HIPs) were consecutively enrolled. 47.95% (70/146) of cases and 53.97% (34/63) were defined as HIPs in the training and testing datasets, respectively. There was more lipid core, more intraplaque hemorrhage, and less calcification in the HIPs compared to the non-highly inflammatory plaques (NHIPs) in the training dataset (p = 0.002, 0.019, and 0.013, respectively). Notably, the incidence of indistinct PVAT (IPVAT) in HIPs was higher than that in NHIPs, both in the training (81.43% vs. 46.05%; p < 0.001) and the testing (88.24% vs. 58.62%; p = 0.007) datasets. The correlations between plaque MRI characteristics and [18F]FDG uptake differed between the NHIPs and HIPs. However, IPVAT consistently correlated with SUVmax (r = 0.35, 0.30; p < 0.001, p = 0.002; for NHIPs and HIPs, respectively). The ensemble model that integrates the radiomics of carotid plaque and PVAT outperformed all models in predicting HIP (area under the curve [AUC] = 0.92/0.91, training/testing dataset). The follow-up further validated the PET for predicting plaque progression with the same accuracy as the ensemble model (AUC: 0.85 vs. 0.79).
Conclusions: The ensemble model integrating the radiomics of carotid plaque and perivascular adipose tissue provides an equivalent tool to PET in the visualization of the evaluation of carotid atherosclerosis inflammation and progression.
EJNMMI ResearchRADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING&nb-
CiteScore
5.90
自引率
3.10%
发文量
72
审稿时长
13 weeks
期刊介绍:
EJNMMI Research publishes new basic, translational and clinical research in the field of nuclear medicine and molecular imaging. Regular features include original research articles, rapid communication of preliminary data on innovative research, interesting case reports, editorials, and letters to the editor. Educational articles on basic sciences, fundamental aspects and controversy related to pre-clinical and clinical research or ethical aspects of research are also welcome. Timely reviews provide updates on current applications, issues in imaging research and translational aspects of nuclear medicine and molecular imaging technologies.
The main emphasis is placed on the development of targeted imaging with radiopharmaceuticals within the broader context of molecular probes to enhance understanding and characterisation of the complex biological processes underlying disease and to develop, test and guide new treatment modalities, including radionuclide therapy.